NYSE: GSK

Explore the latest insights on NYSE: GSK and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of NYSE: GSK’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio
CompanyDeals

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio

Yifan Pharmaceutical (SHE: 002019) announced that it has officially signed a commercialization agreement with Eisai Co., Ltd. (TYO: 4523). Under the terms, Yifan Pharmaceutical will obtain exclusive rights to import,…

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Roche Reports 9M 2026 Sales of CHF 46.493 Billion, Up 6% at CER – Ocrevus Leads as Pharmaceuticals Division Drives Growth and Full-Year Guidance Is Confirmed

Roche Reports 9M 2026 Sales of CHF 46.493 Billion, Up 6% at CER – Ocrevus Leads as Pharmaceuticals Division Drives Growth and Full-Year Guidance Is Confirmed

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
GSK plc Enters Exclusive Option Agreement with Duality Biologics for ADC Candidate DB-1324
CompanyDeals

GSK plc Enters Exclusive Option Agreement with Duality Biologics for ADC Candidate DB-1324

GSK plc Receives EC Approval for Single-Vial Menveo Vaccine for Meningococcal Disease
CompanyDrug

GSK plc Receives EC Approval for Single-Vial Menveo Vaccine for Meningococcal Disease

GSK's Blenrep BLA for Multiple Myeloma Treatments Accepted by FDA for Review
CompanyDrug

GSK’s Blenrep BLA for Multiple Myeloma Treatments Accepted by FDA for Review

GSK's Arexvy Receives MHLW Approval for Expanded RSV Indication in Japan
CompanyDrug

GSK’s Arexvy Receives MHLW Approval for Expanded RSV Indication in Japan

GSK's Linerixibat Demonstrates Efficacy in Phase III GLISTEN Study for Cholestatic Pruritus
CompanyDrug

GSK’s Linerixibat Demonstrates Efficacy in Phase III GLISTEN Study for Cholestatic Pruritus

GSK's Blenrep Shows Survival Benefit in Phase III Multiple Myeloma Study
CompanyDrug

GSK’s Blenrep Shows Survival Benefit in Phase III Multiple Myeloma Study

Vesalius Therapeutics Partners with GSK for Novel Parkinson's Disease Treatments
CompanyDeals

Vesalius Therapeutics Partners with GSK for Novel Parkinson’s Disease Treatments

GSK Leaves BIO, Joining Other Major Companies in Withdrawing Membership
Company

GSK Leaves BIO, Joining Other Major Companies in Withdrawing Membership

Show More